Leslie M. Magnus
Corporate Officer/Principal bei SYNERGY PHARMACEUTICALS INC
Aktive Positionen von Leslie M. Magnus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2015 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | - |
Karriereverlauf von Leslie M. Magnus
Ehemalige bekannte Positionen von Leslie M. Magnus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Leslie M. Magnus
| Brown University | Undergraduate Degree |
| Albany State University (Georgia) | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Leslie M. Magnus
- Erfahrung
